Myers M G
Drugs. 1986;31 Suppl 4:184-91. doi: 10.2165/00003495-198600314-00022.
Recent studies have confirmed the benefits of treating hypertension in the elderly. Thiazide diuretics appear to be effective in achieving goal blood pressure in a majority of patients above the age of 60 years. Increasing concern regarding the biochemical abnormalities associated with diuretic therapy has led to the more widespread use of lower doses of these agents. Preliminary results from a study of hydrochlorothiazide +/- amiloride treatment in 99 hypertensive patients aged 65 to 80 years indicate that hydrochlorothiazide 25 to 50 mg/day will lower diastolic blood pressure to less than 90 mmHg in about 90% of elderly patients with mild to moderate elevations in blood pressure. These lower dosages of hydrochlorothiazide were only occasionally associated with mild hypokalaemia. However, the addition of amiloride to the treatment regimen resulted in the maintenance of normal serum potassium concentrations. Thus, relatively low doses of thiazide diuretics may effectively lower blood pressure in elderly hypertensive patients while causing fewer biochemical abnormalities than previously associated with the use of these drugs.
近期研究证实了老年高血压治疗的益处。噻嗪类利尿剂似乎能有效使大多数60岁以上患者的血压达标。对与利尿剂治疗相关生化异常的日益关注,导致这些药物更低剂量的更广泛使用。一项对99名65至80岁高血压患者进行氢氯噻嗪±阿米洛利治疗的研究初步结果表明,氢氯噻嗪25至50毫克/天可使约90%轻度至中度血压升高的老年患者舒张压降至90毫米汞柱以下。这些较低剂量的氢氯噻嗪仅偶尔与轻度低钾血症相关。然而,在治疗方案中添加阿米洛利可维持血清钾浓度正常。因此,相对低剂量的噻嗪类利尿剂可能有效降低老年高血压患者的血压,同时引起的生化异常比以前使用这些药物时更少。